Molecular subtypes and outcomes in regorafenib-treated patients with metastatic colorectal cancer (mCRC) enrolled in the CORRECT trial.
Year: 2015
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Michael Teufel, Susanne Schwenke, Henrik Seidel, Georg Beckmann, Joachim Reischl, Richardus Vonk, Heinz-Josef Lenz, Josep Tabernero, Salvatore Siena, Axel Grothey, Eric Van Cutsem, Michael Jeffers, Scott Wilhelm, Andrea Wagner, Dirk Laurent, Svetlana Kobina, Mark Daniel Rutstein, Pratyaksha Wirapati, Justin Guinney, Sabine Tejpar
Institutions: USC Norris Comprehensive Cancer Center, Vall d'Hebron Hospital Universitari, Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, Mayo Clinic, Universitair Ziekenhuis Leuven, Bayer (United States), Bayer (Germany), SIB Swiss Institute of Bioinformatics, Sage Bionetworks, KU Leuven
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2592898585